LOINC part LP441587-5 - A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%

A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%

Part LP441587-5COMPONENT

1 tests use this part

LOINC	Name
105496-4	A study of chemotherapy decreased the risk of dying from colon cancer (qualitative, about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%)